All Stories

  1. Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series

    Article • February 2019, Dove Medical Press

    Dr Tetsuo Shimizu

  2. Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

    Article • November 2018, Dove Medical Press

    Dr Tetsuo Shimizu

  3. Inpatient phase-advance therapy for delayed sleep–wake phase disorder: a retrospective study

    Article • Nature and Science of Sleep, October 2018, Dove Medical Press

    Dr Tetsuo Shimizu

  4. Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation

    Article • May 2018, Dove Medical Press

    Dr Tetsuo Shimizu

  5. Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

    Article • May 2018, Dove Medical Press

    Dr Tetsuo Shimizu

  6. Incidence of venous thromboembolism in psychiatric inpatients: a chart review

    Article • May 2018, Dove Medical Press

    Dr Tetsuo Shimizu

  7. Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness

    Article • February 2018, Dove Medical Press

    Dr Tetsuo Shimizu

  8. NMDA receptor antibody could be a cause of catatonic symptoms

    Article • February 2017, Dove Medical Press

    Dr Tetsuo Shimizu

  9. Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia

    Article • October 2014, Taylor & Francis

    Dr Tetsuo Shimizu